Mela Sciences Inc ( NASDAQ: MELA ) got approval from European Union about its Melafind device to detect Melanoma in early stages. Company has been waiting since long to get approval from USFDA. After being approved from Europe and get CE mark to use the device in European countries, probability of getting quick USFDA approval higher as company is all set to market the device in USA and Europe. Traders and investors might taking positions before the final pop in the stock price, due to positive response from USFDA. Small investors might consider taking small positions in the stock to get healthy returns before it might run away.

Our Call: Initiate a buy positions for investment purpose to get maximum returns from it.